‘Superior’ CLL regimen cuts chemo in halfJune 28, 2022CLLCellular TherapyMixed TopicsGene TherapyMyelodysplastic SyndromeAML
FDA approves liso-cel as second-line therapy for LBCLJune 27, 2022B Cell LymphomaMixed TopicsCellular TherapyGene TherapyCLL
Studies address ibrutinib bleeding risk in patients with CLL receiving Mohs surgeryMay 31, 2022CLLMixed Topics
Third-generation Black woman physician makes cancer research historyMay 24, 2022Mixed TopicsALLB Cell LymphomaHodgkin LymphomaMantle Cell LymphomaDiversity in MedicineAML
Ex–hospital porter a neglected giant of cancer researchMay 11, 2022ALLAggressive LymphomasB Cell LymphomaCLLDLBCLMantle Cell LymphomaMultiple Myeloma
Survivor’s story foreshadows one of oncology’s greatest successesApril 14, 2022Hodgkin LymphomaTransplantCLL
A little-known offshoot of hem/onc opens pathway for professional developmentMarch 31, 2022Mixed TopicsBusiness of MedicineCLL
